7Baggers
 Maxim Group Upgrades Adial Pharmaceuticals (ADIL)  Nasdaq Wed, 01 Oct 2025 00:06:00 GMT
 Adial Pharmaceuticals (ADIL) Upgraded by Maxim Group | ADIL Stoc  GuruFocus Tue, 30 Sep 2025 13:24:36 GMT
 adial pharmaceuticals provides business update following  GlobeNewswire Wed, 17 Sep 2025 00:20:01 GMT
 Adial Pharmaceuticals Provides Business Update Following  GlobeNewswire Tue, 16 Sep 2025 12:05:09 GMT
 Adial Pharmaceuticals Advances AD04 with FDA Support  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 14:42:13  Newser Fri, 05 Sep 2025 19:42:13 GMT
 adial pharmaceuticals granted a 180 calendar day extension  GlobeNewswire Thu, 04 Sep 2025 04:54:54 GMT
 published on: 2025-09-03 12:27:20  Newser Wed, 03 Sep 2025 17:27:20 GMT
 published on: 2025-09-03 02:15:20  Newser Wed, 03 Sep 2025 07:15:20 GMT
 Adial Pharmaceuticals Granted a 180 Calendar Day Extension  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 Adial Pharmaceuticals Granted Nasdaq Compliance Extension  TipRanks Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 14:51:42  Newser Tue, 02 Sep 2025 19:51:42 GMT
 published on: 2025-09-01 12:16:11  beatles.ru Mon, 01 Sep 2025 08:16:11 GMT

Adial Pharmaceuticals, Inc
(NASDAQ:ADIL) 

ADIL stock logo

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment o...

Founded: 2010
Full Time Employees: 3
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends